Clayton Springer
Novartis (France)(FR)Novartis (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Advanced Chemical Physics Studies, Machine Learning in Materials Science, Innovative Microfluidic and Catalytic Techniques Innovation, Semiconductor Quantum Structures and Devices
Most-Cited Works
- → Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer(2018)123 cited
- → Simulations of femtosecond laser-induced desorption of CO from Cu(100)(1994)88 cited
- → In Silico Prediction of Volume of Distribution in Human Using Linear and Nonlinear Models on a 669 Compound Data Set(2009)84 cited
- → The Role of the Acidity of N-Heteroaryl Sulfonamides as Inhibitors of Bcl-2 Family Protein–Protein Interactions(2013)73 cited
- → Fluorinated Compounds in Medicinal Chemistry: Recent Applications, Synthetic Advances and Matched-Pair Analyses(2014)70 cited
- → Chalcone, Acyl Hydrazide, and Related Amides Kill Cultured Trypanosoma brucei brucei(2000)66 cited